Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical BupIvacaIn-d9 10mg
SDP

Supplier:  Cayman Chemical 1824610 MG

Encompass_Preferred

A multi-kinase inhibitor that inhibits VEGFR2 VEGFR3 VEGFR1 EGFR PDGFRB Tie-2 and FGFR1 (IC50s 40 110 1600 500 1100 2500 and 3600 nM respectively in cell-free assays) also binds to 142 additional kinases in a panel of 442 kinases (Kds 4.6-7900 nM) induces apoptosis and cell cycle arrest at the G0/G1 phase in GEO colon and OVCAR-3 ovarian cancer cells at 1 and 2.5 UM inhibits proliferation of HAK1-B KYN-2 and Huh7 hepatocarcinoma cells and HUVECs (IC50s 10 8.1 9.4 and 7.1 UM respectively) increases survival and decreases tumor angiogenesis and VEGFR2 levels in a D54MG glioblastoma mouse xenograft model at 200 mg/kg reduces tumor growth in a variety of mouse xenograft models at 25-100 mg/kg per day

Catalog No. 50-296-5808


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.